<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492017000300132</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características del uso de psicofármacos en niños hospitalizados]]></article-title>
<article-title xml:lang="en"><![CDATA[Use of psychtropic drugs in hospitalized children]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ackermann]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[Noelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Catenaccio]]></surname>
<given-names><![CDATA[Valentina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Telechea]]></surname>
<given-names><![CDATA[Héctor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,UDELAR Facultad de Medicina Depto. Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,UDELAR Facultad de Medicina Depto. Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,UDELAR Facultad de Medicina Depto. Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,UDELAR Facultad de Medicina Depto. Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>88</volume>
<numero>3</numero>
<fpage>132</fpage>
<lpage>141</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492017000300132&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492017000300132&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492017000300132&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción  a nivel nacional la prevalencia estimada de problemas emocionales y conductuales en niños es 20%. Los psicofármacos constituyen uno de los recursos terapéuticos dentro de su abordaje multimodal. Su uso a nivel mundial está en aumento.  Objetivo  describir la frecuencia y caracterizar el uso de psicofármacos en menores de 15 años hospitalizados en el Centro Hospitalario Pereira Rossell.  Material y métodos  se realizó una encuesta a padres y/o tutores de niños (2 años hospitalizados entre febrero y abril de 2014, previo consentimiento informado verbal y autorización del protocolo por la Dirección del Centro. Las variables fueron: frecuencia de consumo, tipo de psicofármaco, politerapia, duración, conocimiento sobre motivo de la indicación, tipo de profesional que indicó y monitorizó el tratamiento, frecuencia de tratamientos no farmacológicos.  Resultados  se encuestaron 608 cuidadores; consumían 74 psicofármacos 46 niños (7,6%, IC95% 5,1-9,7%); edad media 10 años. Risperidona fue el más frecuente (33/46). Se identificó uso (2 psicofármacos en 21/46 niños. La asociación más frecuente fue antipsicóticos con estabilizantes del humor. Al momento de la entrevista el consumo era (1 año en 58%. En 89% de los casos el seguimiento era realizado por un psiquiatra. Recibía tratamiento no farmacológico 50%.  Conclusión  en esta población predominó el uso de risperidona y la combinación de antipsicóticos con estabilizantes del humor. Se destaca la baja proporción de pacientes en tratamiento multimodal y la necesidad de jerarquizar el rol del pediatra en la monitorización y coordinación de estos tratamientos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction  the estimated prevalence of emotional and behavioral problems in children is 20% at the national level. Psychotropic drugs are one of the therapeutic resources within their multimodal approach. Currently, there is a global increase in the use of these drugs.  Objective  to describe the frequency and to characterize the use of psychotropic drugs in children under 15 years old, who are hospitalized at the Pereira Rossell Hospital Center (CHPR).  Methods  a survey to parents and/or guardians of children older than 2 years old who were hospitalized between February and April 2014 was conducted, subsequent to their verbal informed consent and the hospital&#8217;s authorization of the protocol. The variables were the following: frequency of use, type of psychotropic drug, polytherapy, duration, source of knowledge about indication, type of professional treatment indicated and monitored, frequency of non-pharmacological treatments.  Results  608 caregivers were surveyed; 46 children consumed 74 psychotropic drugs (7.6%, 95% CI 5.1 to 9.7%); average age 10 years old. Risperidone was the most frequently used drug (33/46). 21/46 children used 2 or more psychotropic drugs. The most frequent association was antipsychotics with mood stabilizers. At the time of the interview consumption was over one year for 58% of children in the study. In 89% of cases a psychiatrist was responsible for monitoring. 50% of children received no drug treatment.  Conclusion  the use of risperidone and the combination of antipsychotics with mood stabilizers prevails in this population. The study found a low proportion of patients was under multimodal treatment. It is necessary to prioritize the role of pediatricians in monitoring and coordinating these treatments.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Psicotrópicos]]></kwd>
<kwd lng="es"><![CDATA[Utilización de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Pediatría.]]></kwd>
<kwd lng="en"><![CDATA[Psychotropic Drugs]]></kwd>
<kwd lng="en"><![CDATA[Drug utilization]]></kwd>
<kwd lng="en"><![CDATA[Pediatrics.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Características epidemiológicas de la salud mental de los niños montevideanos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viola]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Psiquiatr Urug]]></source>
<year>2008</year>
<volume>72</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-20</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pediatric psychopharmacology: context, model programs, and considerations for care]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pidano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Honigfeld]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Psychiatr Serv]]></source>
<year>2012</year>
<volume>63</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>929-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Características epidemiológicas del trastorno por déficit atencional en los escolares uruguayos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viola]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Psiquiatr Urug]]></source>
<year>2009</year>
<volume>73</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>157-68</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeMaso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Walter]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento psicológico de los niños y adolescentes]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Kliegman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Behrman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jenson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Stanton]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Nelson tratado de pediatría]]></source>
<year>2009</year>
<edition>18</edition>
<page-range>105-50</page-range><publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pascual-Castroviejo]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trastornos por déficit de atención e hiperactividad (TDAH)]]></source>
<year>2008</year>
<page-range>140-50</page-range><publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Española de Pediatría]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<collab>American Psychiatric Association</collab>
<source><![CDATA[DSM-IV: diagnostic and statistical manual of mental disorders]]></source>
<year>2000</year>
<edition>4</edition>
<publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
<publisher-name><![CDATA[American Psychiatric Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalencia de síndrome de déficit de atención con hiperactividad (AD/HD) en niños de edad escolar en algunos colegios primarios de la ciudad de Rosario, Santa Fe, Argentina.]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nardelli]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Piola]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Retel]]></source>
<year>2013</year>
<volume>39</volume>
<page-range>23-33</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Algoritmo de Tratamiento Multimodal para Preescolares Latinoamericanos con Trastorno por Déficit de Atención con Hiperactividad (TDAH)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palacio]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bauermeister]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Montiel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Henao]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Agosta]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Salud Mental]]></source>
<year>2009</year>
<volume>32</volume>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Uso de metilfenidato en niños y adolescentes usuarios de servicios de asistencia pública de Montevideo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Goyeneche]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreiro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Olmos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bauger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oyarzun]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2008</year>
<volume>79</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>277-83</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Farmacoepidemiología de psicofármacos empleados en la práctica pediátrica en el Servicio de Psiquiatría Infantil del Hospital General de Durango, México]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lares]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alanis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Guillé]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Loera]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2010</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-36</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Frecuencia de administración de psicoestimulantes en escolares de primero a sexto básico en Talca.]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buttinghausen]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Elizalde]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tapia]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Figueroa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Huidobro]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chil Neuropsiquiatr]]></source>
<year>2011</year>
<volume>49</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>258-64</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Trastorno por déficit de atención con hiperactividad: una actualización.]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Bol Pediatr]]></source>
<year>2007</year>
<volume>47</volume>
<numero>200</numero>
<issue>200</issue>
<page-range>116-24</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents]]></article-title>
<collab>Subcommittee on Attention-Deficit/Hyperactivity Disorder</collab>
<collab>Steering Committee on Quality Improvement and Management</collab>
<source><![CDATA[Pediatrics]]></source>
<year>2011</year>
<volume>128</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1007-22</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento farmacológico del trastorno por déficit de atención con hiperactividad]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Atienza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Psiquiatr Psicol Niño y del Adoles]]></source>
<year>2006</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>20-43</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faraone]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Buitelaar]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Child Adolesc Psychiatry]]></source>
<year>2010</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>353-64</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Psicofármacos en niños y adolescentes: revisión y situación actual]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mollejo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Asoc Esp Neuropsiquiatr]]></source>
<year>2005</year>
<volume>25</volume>
<numero>95</numero>
<issue>95</issue>
<page-range>141-50</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Controversias sobre el uso de psicofármacos en niños y adolescentes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sauceda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2005</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>369-71</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Efectos de los psicoestimulantes en el desempeño cognitivo y conductual de los niños con déficit de atención e hiperactividad subtipo combinado]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mulas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Roselló]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Morant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pitarch]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Neurol]]></source>
<year>2002</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-24</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Self-reported side effects in children and adolescents taking risperidone]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walter]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Soh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cleary]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Australas Psychiatry]]></source>
<year>2010</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento farmacológico con risperidona en niños con trastornos en el comportamiento]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mulas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roselló]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Neurol]]></source>
<year>2001</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>201-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Obesidad, diabetes e hiperlipidemia en niños y adolescentes como efecto metabólico de los antipsicóticos atípicos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Trastor Ánimo]]></source>
<year>2007</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-54</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Caracteristicas das prescricoes no transtorno de déficit de atencao/hiperatividade]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camargos]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolato]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[J Bras Psiquiatr]]></source>
<year>2009</year>
<volume>58</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>195-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Comunicado sobre Metilfenidato.]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tamaño de la muestra]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mateu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Casal]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Epidem Med Prev]]></source>
<year>2003</year>
<volume>1</volume>
<page-range>8-14</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O' Brien]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adicción y abuso de drogas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Brunton]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Goodman &amp; Gilman Las bases farmacológicas de la terapéutica]]></source>
<year>2003</year>
<edition>11</edition>
<page-range>607-27</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill Interamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Míguez Passada]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
</person-group>
<source><![CDATA[La sujeción de los cuerpos dóciles: medicación abusiva con psicofármacos en la niñez uruguaya]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Estudios Sociológicos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="book">
<collab>Ministerio de Salud</collab>
<collab>Dirección General de Medicamentos, Insumos y Drogas</collab>
<source><![CDATA[Glosario]]></source>
<year>s.d.</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[DIGEMID]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cuadrado]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Saavedra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mellado]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<collab>Comité de Medicamentos Pediátricos de la Asociación Española de Pediatría</collab>
<source><![CDATA[Situación de uso de fármacos en niños: definiciones]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEP]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
